Literature DB >> 7479890

Asbestos and mesothelioma: genetic lessons from a tragedy.

A Knudson1.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7479890      PMCID： PMC40522          DOI： 10.1073/pnas.92.24.10819

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  21 in total

1.  Asbestos exposure, smoking, and neoplasia.

Authors:  I J Selikoff; E C Hammond; J Churg
Journal:  JAMA       Date:  1968-04-08       Impact factor: 56.272

2.  G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.

Authors:  T Kudoh; T Ishidate; M Moriyama; K Toyoshima; T Akiyama
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

3.  Physical and functional interaction between WT1 and p53 proteins.

Authors:  S Maheswaran; S Park; A Bernard; J F Morris; F J Rauscher; D E Hill; D A Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

4.  The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.

Authors:  S Park; M Schalling; A Bernard; S Maheswaran; G C Shipley; D Roberts; J Fletcher; R Shipman; J Rheinwald; G Demetri
Journal:  Nat Genet       Date:  1993-08       Impact factor: 38.330

5.  Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma.

Authors:  T Taguchi; S C Jhanwar; J M Siegfried; S M Keller; J R Testa
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

6.  A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor.

Authors:  J A Trofatter; M M MacCollin; J L Rutter; J R Murrell; M P Duyao; D M Parry; R Eldridge; N Kley; A G Menon; K Pulaski
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

7.  Rates of p16 (MTS1) mutations in primary tumors with 9p loss.

Authors:  P Cairns; L Mao; A Merlo; D J Lee; D Schwab; Y Eby; K Tokino; P van der Riet; J E Blaugrund; D Sidransky
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

8.  p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.

Authors:  J Q Cheng; S C Jhanwar; W M Klein; D W Bell; W C Lee; D A Altomare; T Nobori; O I Olopade; A J Buckler; J R Testa
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

9.  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2.

Authors:  G A Rouleau; P Merel; M Lutchman; M Sanson; J Zucman; C Marineau; K Hoang-Xuan; S Demczuk; C Desmaze; B Plougastel
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

10.  Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer.

Authors:  Y Sekido; H I Pass; S Bader; D J Mew; M F Christman; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  1995-03-15       Impact factor: 12.701
View more
  2 in total

1.  Neurofibromatosis 2 (NF2) and malignant mesothelioma in a man with a constitutional NF2 missense mutation.

Authors:  M E Baser; H Rai; A J Wallace; D G R Evans
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

2.  Phenotypes and karyotypes of human malignant mesothelioma cell lines.

Authors:  Vandana Relan; Leanne Morrison; Kylie Parsonson; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Kwun M Fong; Rayleen V Bowman
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.